Status:
COMPLETED
Fluid Status of Dialysis Subjects
Lead Sponsor:
HemoCept Inc.
Conditions:
ESRD (End Stage Renal Disease)
Eligibility:
All Genders
18-75 years
Brief Summary
The goal of this clinical pilot study is to evaluate the ability of the device to properly detect the hydration status of the subject through the study of fluid removal data during dialysis and HemoCe...
Eligibility Criteria
Inclusion
- Study or representatives must have voluntarily signed the informed consent form before any study related procedures
- Subjects can be any gender, but must be between (and including) 18 and 75 years of age
- Subject has been on dialysis for more than 90 days and has been diagnosed with end stage kidney disease
- Subject is willing and able to provide informed consent and HIPAA authorization • Subject is able and willing to meet all study requirements
- Subject is able to place electrodes on bilateral deltoids and above the pant line on the waist
Exclusion
- Subject is pregnant, breast-feeding, or intends to become pregnant during the course of the study.
- Subject has a personal medical history that includes:
- Long Q-T syndrome
- Cardiac channelopathies, genetic heart defects
- Seizures
- Acute untreated blood clotting disorders or acute untreated bleeding disorders
- Subject has had a heart transplant.
Key Trial Info
Start Date :
March 19 2025
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 9 2025
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT07217041
Start Date
March 19 2025
End Date
June 9 2025
Last Update
October 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sierra Nevad Specialty Care
Reno, Nevada, United States, 89511